We support our Publishers and Content Creators. You can view this story on their website by CLICKING HERE.
Moderna formally requested emergency use authorization for its COVID-19 vaccine for children aged 6 months to 6 years, which would make it the first shot available for children under the age of 5. Trial data showed the young patients showed a similar immune system response as young adults who received two doses.
The trials involved roughly 6,700 participants who received two doses, each a quarter of a regular dose. Data showed the vaccine reduced symptomatic cases by 43.7% in children aged 6 months to 2 years and 37.5% in children aged 2 to 6 years. It is unclear how many will be vaccinated in the age group; only 28% of children 5 to 11 years old are fully vaccinated. Roughly 13 million cases of COVID-19 have been reported in those aged 18 and under.
In the US, the seven-day rolling average of newly reported cases is just above 52,000 per day (see data). Meanwhile, residents in Beijing began taking mandatory COVID-19 tests as a rising number of cases have invoked fears of a Shanghai-like lockdown.